Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives

Staphylococcus aureus, an opportunistic pathogen, can root several infections viz skin and tissue infections, bacteraemia, food poisoning, pneumonia, and many other clinical conditions with some variations of virulence factors. In treatment of infections, caused by this Gram-positive pathogen, sever...

Full description

Bibliographic Details
Main Authors: Hassan Rafique, Nazim Hussain, Muhammad Usama Saeed, Hafiz M.N. Iqbal, Gulfam Azim, Muhammad Bilal
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2022-09-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/linezolid-resistance-staphylococcus-aureus-prevalence-emerging-resistance-mechanisms-challenges-and-perspectives/
_version_ 1817979316537917440
author Hassan Rafique
Nazim Hussain
Muhammad Usama Saeed
Hafiz M.N. Iqbal
Gulfam Azim
Muhammad Bilal
author_facet Hassan Rafique
Nazim Hussain
Muhammad Usama Saeed
Hafiz M.N. Iqbal
Gulfam Azim
Muhammad Bilal
author_sort Hassan Rafique
collection DOAJ
description Staphylococcus aureus, an opportunistic pathogen, can root several infections viz skin and tissue infections, bacteraemia, food poisoning, pneumonia, and many other clinical conditions with some variations of virulence factors. In treatment of infections, caused by this Gram-positive pathogen, several antibiotics are being used importantly Methicillin and Vancomycin. This pathogen has high capability of antibiotic resistance development and had evolved new strains such as Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-resistant Staphylococcus aureus (VRSA). Meta-analysis in Ethiopia showed that pooled prevalence of MRSA in environment, food, animal, and human was 54%, 77%, 15%, and 38% respectively (2022). Risk of MRSA isolates from burn ICU was 55 % higher (2018). In Bangladesh, 37.1% isolates from frozen meat chicken (2021) were identified as MRSA. This problem is being dealt with a novel drug called Linezolid which has been proved effective against both MRSA and VRSA. Exacerbating the situation, this pathogen has shown resistance against this unprecedented drug by means of a number of drug resistance mechanisms. Its prevalence has been reporting since the adoption of the drug, but with a minute ratio at one time/place to the very high percentage at another time/place. This inconsistent prevalence must not be ignored, and its surveillance should be augmented as antibiotic treatment is critical for fighting against microbial infections. This review highlights the worldwide reports in which Staphylococcus aureus of either wildtype or Methicillin or Vancomycin resistance that have shown resistance to Linezolid drug for the past 2 decades. At the same time where incidences of Linezolid Resistant Staphylococcus aureus (LRSA) indications are reporting, there is a call for comprehensive strategies to overcome this challenge of antibiotic resistance.
first_indexed 2024-04-13T22:41:19Z
format Article
id doaj.art-cb8a99ed49b34c1cb1bf521606741bf1
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-04-13T22:41:19Z
publishDate 2022-09-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-cb8a99ed49b34c1cb1bf521606741bf12022-12-22T02:26:37ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2022-09-0116314921505https://doi.org/10.22207/JPAM.16.3.44Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and PerspectivesHassan RafiqueNazim HussainMuhammad Usama SaeedHafiz M.N. Iqbalhttps://orcid.org/0000-0003-4855-2720Gulfam AzimMuhammad Bilalhttps://orcid.org/0000-0001-5388-3183Staphylococcus aureus, an opportunistic pathogen, can root several infections viz skin and tissue infections, bacteraemia, food poisoning, pneumonia, and many other clinical conditions with some variations of virulence factors. In treatment of infections, caused by this Gram-positive pathogen, several antibiotics are being used importantly Methicillin and Vancomycin. This pathogen has high capability of antibiotic resistance development and had evolved new strains such as Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-resistant Staphylococcus aureus (VRSA). Meta-analysis in Ethiopia showed that pooled prevalence of MRSA in environment, food, animal, and human was 54%, 77%, 15%, and 38% respectively (2022). Risk of MRSA isolates from burn ICU was 55 % higher (2018). In Bangladesh, 37.1% isolates from frozen meat chicken (2021) were identified as MRSA. This problem is being dealt with a novel drug called Linezolid which has been proved effective against both MRSA and VRSA. Exacerbating the situation, this pathogen has shown resistance against this unprecedented drug by means of a number of drug resistance mechanisms. Its prevalence has been reporting since the adoption of the drug, but with a minute ratio at one time/place to the very high percentage at another time/place. This inconsistent prevalence must not be ignored, and its surveillance should be augmented as antibiotic treatment is critical for fighting against microbial infections. This review highlights the worldwide reports in which Staphylococcus aureus of either wildtype or Methicillin or Vancomycin resistance that have shown resistance to Linezolid drug for the past 2 decades. At the same time where incidences of Linezolid Resistant Staphylococcus aureus (LRSA) indications are reporting, there is a call for comprehensive strategies to overcome this challenge of antibiotic resistance.https://microbiologyjournal.org/linezolid-resistance-staphylococcus-aureus-prevalence-emerging-resistance-mechanisms-challenges-and-perspectives/linezolidantibacterial resistancelinezolid resistant staphylococcus aureus
spellingShingle Hassan Rafique
Nazim Hussain
Muhammad Usama Saeed
Hafiz M.N. Iqbal
Gulfam Azim
Muhammad Bilal
Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
Journal of Pure and Applied Microbiology
linezolid
antibacterial resistance
linezolid resistant staphylococcus aureus
title Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
title_full Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
title_fullStr Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
title_full_unstemmed Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
title_short Linezolid-resistance Staphylococcus aureus – Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
title_sort linezolid resistance staphylococcus aureus prevalence emerging resistance mechanisms challenges and perspectives
topic linezolid
antibacterial resistance
linezolid resistant staphylococcus aureus
url https://microbiologyjournal.org/linezolid-resistance-staphylococcus-aureus-prevalence-emerging-resistance-mechanisms-challenges-and-perspectives/
work_keys_str_mv AT hassanrafique linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives
AT nazimhussain linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives
AT muhammadusamasaeed linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives
AT hafizmniqbal linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives
AT gulfamazim linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives
AT muhammadbilal linezolidresistancestaphylococcusaureusprevalenceemergingresistancemechanismschallengesandperspectives